journal article·2025-02-01Open access

Ultrafast optical and passive acoustic mapping characterization of nanoscale cavitation nuclei based on gas vesicle proteins

Cameron A. B. Smith, Avinoam Bar-Zion, Qiang Wu, Dina Malounda, Luca Bau, Eleanor Stride, Mikhail G. Shapiro, Constantin C. Coussios

AIP Advances· Volume 15· Issue 2

Abstract

Genetically encodable gas-filled particles, known as gas vesicles (GVs), have shown promise as a biomolecular contrast agent for ultrasound imaging and have the potential to be used as cavitation nuclei for ultrasound therapy. In this study, we used passive acoustic mapping techniques to characterize GV-seeded cavitation, utilizing 0.5 and 1.6 MHz ultrasound insonation over peak rarefactional pressures ranging from 100 to 2200 kPa. We found that GVs produce cavitation for the duration of the first applied pulse, up to at least 5000 cycles, but that bubble activity diminishes rapidly over subsequent pulses. At 0.5 MHz, the frequency content of cavitation emissions was predominantly broadband in nature, while at 1.6 MHz, narrowband content at harmonics of the main excitation frequency dominated. Simulations and high-speed camera imaging suggest that the received cavitation emissions come not from individual GVs but instead from the coalescence of GV-released gas into larger bubbles during the applied ultrasound pulse. These results will aid the future development of GVs as cavitation nuclei in ultrasound therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ultrasound and Hyperthermia Applications · Ultrasound and Cavitation Phenomena · Photoacoustic and Ultrasonic Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Chemistry and Chemical Engineering, California Institute of Technology 1 , Pasadena, California 91125,

Department of Engineering Science, University of Oxford 2 , Oxford OX1 3PJ,

Andrew and Peggy Cherng Department of Medical Engineering, California Institute of Technology 3 , Pasadena, California 91125,

Howard Hughes Medical Institute, California Institute of Technology 4 , Pasadena, California 91125,

Funding

Human Frontier Science Program · National Institutes of Health · David and Lucile Packard Foundation · Chan Zuckerberg Initiative

References (44)

Show source-provided references
1. The blood–brain barrier and blood–tumour barrier in brain tumours and metastases10.1038/s41568-019-0205-x ↗
2. Noninvasive MR imaging–guided focal opening of the blood-brain barrier in rabbits10.1148/radiol.2202001804 ↗
3. Therapeutic agent delivery across the blood–brain barrier using focused ultrasound10.1146/annurev-bioeng-062117-121238 ↗
4. Exploitation of sub-micron cavitation nuclei to enhance ultrasound-mediated transdermal transport and penetration of vaccines10.1016/j.jconrel.2016.07.016 ↗
5. Understanding ultrasound induced sonoporation: Definitions and underlying mechanisms10.1016/j.addr.2013.11.008 ↗
6. A basic study on sonoporation with microbubbles exposed to pulsed ultrasound10.1007/s10396-005-0031-5 ↗
7. Opening of endothelial cell–cell contacts due to sonoporation10.1016/j.jconrel.2020.03.038 ↗
8. In situ tumor ablation creates an antigen source for the generation of antitumor immunity10.1158/0008-5472.CAN-03-3949 ↗
9. High-intensity focused ultrasound tumor ablation: Review of ten years of clinical experience10.1007/s11684-010-0092-8 ↗
10. Reasons for different therapeutic effects of high-intensity focused ultrasound ablation on excised uterine fibroids with different signal intensities on T2-weighted MRI: A study of histopathological characteristics10.1080/02656736.2019.1592242 ↗
11. Spatiotemporal assessment of the cellular safety of cavitation-based therapies by passive acoustic mapping10.1016/j.ultrasmedbio.2020.01.009 ↗
12. Spatiotemporal assessment of the cellular safety of cavitation-based therapies by passive acoustic mapping
13. Non-thermal histotripsy tumor ablation promotes abscopal immune responses that enhance cancer immunotherapy10.1136/jitc-2019-000200 ↗
14. Clinical usefulness of SonoVue contrast echocardiography: The thoraxcentre experience10.1007/bf03085955 ↗
15. Development of a new SonovueTM contrast-enhanced ultrasound approach reveals temporal and age-related features of muscle microvascular responses to feeding10.1002/phy2.119 ↗
16. Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound10.1093/jnci/djt305 ↗
17. Ultrasound-propelled nanocups for drug delivery10.1002/smll.201501322 ↗
18. Gas-stabilizing sub-100 Nm mesoporous silica nanoparticles for ultrasound theranostics10.1021/acsomega.0c03377 ↗
19. Proteins, air and water: Reporter genes for ultrasound and magnetic resonance imaging10.1016/j.cbpa.2018.02.011 ↗
20. Biogenic gas nanostructures as ultrasonic molecular reporters10.1038/nnano.2014.32 ↗
21. Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts10.1038/nature25021 ↗
22. Genomically mined acoustic reporter genes for real-time in vivo monitoring of tumors and tumor-homing bacteria10.1038/s41587-022-01581-y ↗
23. Ultrasound imaging of gene expression in mammalian cells10.1126/science.aax4804 ↗
24. Acoustic behavior of halobacterium salinarum gas vesicles in the high-frequency range: Experiments and modeling10.1016/j.ultrasmedbio.2016.12.020 ↗
25. Acoustic characterization of nano gas vesicles
26. The vibration behavior of sub-micrometer gas vesicles in response to acoustic excitation determined via laser Doppler vibrometry10.1002/adfm.202000239 ↗
27. Nonlinear X-wave ultrasound imaging of acoustic biomolecules10.1103/PhysRevX.8.041002 ↗
28. Nonlinear ultrasound imaging of nanoscale acoustic biomolecules10.1063/1.4976105 ↗
29. Ultrafast amplitude modulation for molecular and hemodynamic ultrasound imaging10.1063/5.0050807 ↗
30. Ultrasensitive ultrasound imaging of gene expression with signal unmixing10.1038/s41592-021-01229-w ↗
31. Acoustically triggered mechanotherapy using genetically encoded gas vesicles10.1038/s41565-021-00971-8 ↗
32. Acoustic biosensors for ultrasound imaging of enzyme activity10.1038/s41589-020-0591-0 ↗
33. Use of passive arrays for characterization and mapping of cavitation activity during hifu exposure
34. Quantitative frequency-domain passive cavitation imaging10.1109/TUFFC.2016.2620492 ↗
35. Passive acoustic mapping utilizing optimal beamforming in ultrasound therapy monitoring10.1121/1.4916694 ↗
36. Ultrasound-based triggered drug delivery to tumors10.1007/s13346-017-0448-6 ↗
37. A review of low-intensity ultrasound for cancer therapy10.1016/j.ultrasmedbio.2014.11.019 ↗
38. Nucleation, mapping and control of cavitation for drug delivery10.1038/s42254-019-0074-y ↗
39. Broadband ultrasonic attenuation estimation and compensation with passive acoustic mapping10.1109/TUFFC.2018.2866171 ↗
40. Passive cavitation mapping for localization and tracking of bubble dynamics10.1121/1.3467491 ↗
41. Preparation of biogenic gas vesicle nanostructures for use as contrast agents for ultrasound and MRI10.1038/nprot.2017.081 ↗
42. Gauging the likelihood of stable cavitation from ultrasound contrast agents10.1088/0031-9155/58/1/127 ↗
43. Quantitative observations of cavitation activity in a viscoelastic medium10.1121/1.3626156 ↗
44. Measuring gas vesicle dimensions by electron microscopy10.1002/pro.4056 ↗